TSXV - Delayed Quote CAD

MedX Health Corp (MDX.V)

0.0900 -0.0050 (-5.26%)
At close: April 24 at 2:45 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
602.5660
510.6060
563.1010
530.0660
Cost of Revenue
297.7220
270.6600
289.7620
261.9600
Gross Profit
304.8440
239.9460
273.3400
268.1060
Operating Expense
3,593.0610
4,108.3300
4,836.0860
3,297.5230
Operating Income
-3,288.2170
-3,868.3840
-4,562.7460
-3,029.4170
Net Non Operating Interest Income Expense
-1,993.7070
-1,268.7190
-777.6110
-58.1740
Other Income Expense
9.1390
3.4040
-29.9830
-111.8850
Pretax Income
-5,272.7850
-5,133.6990
-5,370.3400
-3,199.4760
Net Income Common Stockholders
-5,364.5170
-5,133.6990
-5,323.5400
-3,199.4760
Diluted NI Available to Com Stockholders
-5,364.5170
-5,133.6990
-5,323.5400
-3,199.4760
Basic EPS
-0.03
-0.03
-0.03
-0.02
Diluted EPS
-0.03
-0.03
-0.03
-0.02
Basic Average Shares
185,007.7300
183,742.4730
180,184.6800
166,559.3390
Diluted Average Shares
201,942.3170
183,742.4730
180,184.6800
166,559.3390
Total Expenses
3,890.7830
4,378.9900
5,125.8480
3,559.4830
Net Income from Continuing & Discontinued Operation
-5,364.5170
-5,133.6990
-5,323.5400
-3,199.4760
Normalized Income
-5,373.6560
-5,137.1030
-5,293.5570
-3,087.5910
Interest Expense
1,993.7070
1,268.7190
777.6110
58.1740
Net Interest Income
-1,993.7070
-1,268.7190
-777.6110
-58.1740
EBIT
-3,279.0780
-3,864.9800
-4,592.7290
-3,141.3020
EBITDA
-3,239.9440
-3,813.2900
-4,540.9200
-3,061.8510
Reconciled Cost of Revenue
284.9900
253.1780
270.6490
256.9170
Reconciled Depreciation
39.1340
51.6900
51.8090
79.4510
Net Income from Continuing Operation Net Minority Interest
-5,364.5170
-5,133.6990
-5,323.5400
-3,199.4760
Total Unusual Items Excluding Goodwill
9.1390
3.4040
-29.9830
-111.8850
Total Unusual Items
9.1390
3.4040
-29.9830
-111.8850
Normalized EBITDA
-3,249.0830
-3,816.6940
-4,510.9370
-2,949.9660
12/31/2020 - 2/13/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers